Suchergebnisse - "Kast, Richard E"

PubPharm (132)

41

The role of interleukin-18 in glioblastoma pathology implies therapeutic potential of two old drugs—disulfiram and ritonavir

enthalten in: Chinese journal of cancer | 2015

von Kast, R.

42

Regulatory effect of chemokines in bone marrow niche

enthalten in: Cell & tissue research | 2015

von Ahmadzadeh, A. | Kast, R. | Ketabchi, N. | +4

43

Regulatory effect of chemokines in bone marrow niche

enthalten in: Cell & tissue research | 2015

von Ahmadzadeh, A. | Kast, R. | Ketabchi, N. | +4

44

Regulatory effect of chemokines in bone marrow niche

enthalten in: Cell & tissue research | 2015

von Ahmadzadeh, A. | Kast, R. | Ketabchi, N. | +4

45

Agomelatine or ramelteon as treatment adjuncts in glioblastoma and other M1- or M2-expressing cancers

enthalten in: Contemporary oncology (Poznan, Poland) | 2015

von Kast, R.

46

Involvement of MicroRNA in T-Cell Differentiation and Malignancy

enthalten in: International journal of hematology-oncology and stem cell research | 2015

von Saki, N. | Abroun, S. | Soleimani, M. | +4

47

The role of interleukin‐18 in glioblastoma pathology implies therapeutic potential of two old drugs—disulfiram and ritonavir

enthalten in: Cancer Communications | 2015

von Kast, R.

48

CUSP9* treatment protocol for recurrent glioblastoma : aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide

enthalten in: Oncotarget | 2014

von Kast, R. | Karpel-Massler, G. | Halatsch, M.

49

Artesunate enhances the antiproliferative effect of temozolomide on U87MG and A172 glioblastoma cell lines

enthalten in: Anti-cancer agents in medicinal chemistry | 2014

von Karpel-Massler, G. | Westhoff, M. | Kast, R. | +5

50

Oxidizing to death : disulfiram for cancer cell killing

enthalten in: Cell cycle (Georgetown, Tex.) | 2014

von Brüning, A. | Kast, R.

CommentOn: Oncoscience. 2014;1(1):21-9. - PMID 25593981